新型lavendamycin 抗肿瘤剂的合成、代谢及体外细胞毒性研究。
Synthesis, metabolism and in vitro cytotoxicity studies on novel lavendamycin antitumor agents.
机构信息
Chemistry Department, Ball State University, Muncie, IN 47306, USA.
出版信息
Bioorg Med Chem. 2010 Mar 1;18(5):1899-909. doi: 10.1016/j.bmc.2010.01.037. Epub 2010 Jan 25.
Abstract
A series of lavendamycin analogues with two, three or four substituents at the C-6, C-7 N, C-2', C-3' and C-11' positions were synthesized via short and efficient methods and evaluated as potential NAD(P)H:quinone oxidoreductase (NQO1)-directed antitumor agents. The compounds were prepared through Pictet-Spengler condensation of the desired 2-formylquinoline-5,8-diones with the required tryptophans followed by further needed transformations. Metabolism and toxicity studies demonstrated that the best substrates for NQO1 were also the most selectively toxic to NQO1-rich tumor cells compared to NQO1-deficient tumor cells.
摘要
通过短而高效的方法合成了一系列在 C-6、C-7 N、C-2'、C-3' 和 C-11' 位具有两个、三个或四个取代基的 lavendamycin 类似物，并将其评估为潜在的 NAD(P)H:醌氧化还原酶 (NQO1) 导向的抗肿瘤剂。这些化合物通过所需的 2-甲酰基喹啉-5,8-二酮与所需色氨酸的 Pictet-Spengler 缩合，然后进一步进行所需的转化来制备。代谢和毒性研究表明，与 NQO1 缺陷型肿瘤细胞相比，NQO1 最丰富的肿瘤细胞中，NQO1 的最佳底物也是最具选择性毒性的。
相似文献
1
Synthesis, metabolism and in vitro cytotoxicity studies on novel lavendamycin antitumor agents.新型lavendamycin 抗肿瘤剂的合成、代谢及体外细胞毒性研究。
Bioorg Med Chem. 2010 Mar 1;18(5):1899-909. doi: 10.1016/j.bmc.2010.01.037. Epub 2010 Jan 25.
2
Novel lavendamycin analogues as antitumor agents: synthesis, in vitro cytotoxicity, structure-metabolism, and computational molecular modeling studies with NAD(P)H:quinone oxidoreductase 1.新型薰衣草霉素类似物作为抗肿瘤药物：合成、体外细胞毒性、结构代谢以及与NAD(P)H：醌氧化还原酶1的计算分子模拟研究
J Med Chem. 2005 Dec 1;48(24):7733-49. doi: 10.1021/jm050758z.
3
Lavendamycin antitumor agents: structure-based design, synthesis, and NAD(P)H:quinone oxidoreductase 1 (NQO1) model validation with molecular docking and biological studies.薰衣草霉素抗肿瘤剂：基于结构的设计、合成以及通过分子对接和生物学研究对NAD(P)H：醌氧化还原酶1（NQO1）模型进行验证
J Med Chem. 2008 Jun 12;51(11):3104-15. doi: 10.1021/jm701066a. Epub 2008 May 6.
4
Synthesis and evaluation of antitumor activity of novel N-acyllavendamycin analogues and quinoline-5,8-diones.新型N-酰基薰衣草霉素类似物和喹啉-5,8-二酮的合成及其抗肿瘤活性评价
Bioorg Med Chem. 2007 Jan 1;15(1):495-510. doi: 10.1016/j.bmc.2006.09.039. Epub 2006 Oct 10.
5
Novel quinolinequinone antitumor agents: structure-metabolism studies with NAD(P)H:quinone oxidoreductase (NQO1).新型喹啉醌类抗肿瘤药物：与NAD(P)H：醌氧化还原酶（NQO1）的结构-代谢研究
Bioorg Med Chem. 2004 Apr 1;12(7):1667-87. doi: 10.1016/j.bmc.2004.01.021.
6
Novel lavendamycin analogues as potent HIV-reverse transcriptase inhibitors: synthesis and evaluation of anti-reverse transcriptase activity of amide and ester analogues of lavendamycin.新型薰衣草霉素类似物作为有效的HIV逆转录酶抑制剂：薰衣草霉素酰胺和酯类似物的合成及抗逆转录酶活性评估
J Med Chem. 2003 Dec 18;46(26):5773-80. doi: 10.1021/jm0304414.
7
Indolequinone antitumor agents: correlation between quinone structure, rate of metabolism by recombinant human NAD(P)H:quinone oxidoreductase, and in vitro cytotoxicity.吲哚醌抗肿瘤药物：醌结构、重组人NAD(P)H：醌氧化还原酶代谢速率与体外细胞毒性之间的相关性
J Med Chem. 1998 Nov 19;41(24):4755-66. doi: 10.1021/jm980328r.
8
Synthesis of new quinolinequinone derivatives and preliminary exploration of their cytotoxic properties.合成新型喹啉醌衍生物及其细胞毒性的初步探索。
J Med Chem. 2013 May 23;56(10):3806-19. doi: 10.1021/jm301689x. Epub 2013 May 1.
9
3-substituted-5-aziridinyl-1-methylindole-4,7-diones as NQO1-directed antitumour agents: mechanism of activation and cytotoxicity in vitro.作为NQO1导向抗肿瘤剂的3-取代-5-氮丙啶基-1-甲基吲哚-4,7-二酮：体外激活机制和细胞毒性
Biochem Pharmacol. 2003 Oct 1;66(7):1199-206. doi: 10.1016/s0006-2952(03)00452-0.
10
Indolequinone antitumor agents: relationship between quinone structure and rate of metabolism by recombinant human NQO1.吲哚醌抗肿瘤药物：醌结构与重组人NQO1代谢速率之间的关系
Bioorg Med Chem Lett. 1998 Mar 3;8(5):545-8. doi: 10.1016/s0960-894x(98)00069-9.
引用本文的文献
1
Discovery of Sphingosine Kinase Inhibition by Modified Quinoline-5,8-Diones.修饰的喹啉-5,8-二酮对鞘氨醇激酶抑制作用的发现。
Pharmaceuticals (Basel). 2025 Feb 18;18(2):268. doi: 10.3390/ph18020268.
2
Exploring the Therapeutic Marvels: A Comprehensive Review on the Biological Potential of Quinoline-5,8-Dione.探索治疗奇迹：喹啉-5,8-二酮的生物学潜力综合评价
Med Chem. 2024;20(4):385-396. doi: 10.2174/0115734064287677231215070816.
3
Biological activities of polypyridyl-type ligands: implications for bioinorganic chemistry and light-activated metal complexes.多吡啶型配体的生物活性：对生物无机化学和光激活金属配合物的影响。
Curr Opin Chem Biol. 2021 Apr;61:191-202. doi: 10.1016/j.cbpa.2021.01.016. Epub 2021 Mar 30.
4
5,8-Quinolinedione Scaffold as a Promising Moiety of Bioactive Agents.5,8-喹啉二酮作为生物活性试剂的有前途的部分。
Molecules. 2019 Nov 14;24(22):4115. doi: 10.3390/molecules24224115.
5
Intramolecular hydrogen bonding, π-π stacking interactions, and substituent effects of 8-hydroxyquinoline derivative supermolecular structures: a theoretical study.8-羟基喹啉衍生物超分子结构的分子内氢键、π-π堆积相互作用及取代基效应：一项理论研究
J Mol Model. 2019 Jul 23;25(8):241. doi: 10.1007/s00894-019-4140-2.
6
Development of novel amino-quinoline-5,8-dione derivatives as NAD(P)H:quinone oxidoreductase 1 (NQO1) inhibitors with potent antiproliferative activities.新型氨基-喹啉-5,8-二酮衍生物的开发作为 NAD(P)H:醌氧化还原酶 1（NQO1）抑制剂，具有很强的抗增殖活性。
Eur J Med Chem. 2018 Jun 25;154:199-209. doi: 10.1016/j.ejmech.2018.05.025. Epub 2018 May 18.
7
Synthesis, Structure and Cytotoxic Activity of Mono- and Dialkoxy Derivatives of 5,8-Quinolinedione.5,8-喹啉二酮单烷氧基和二烷氧基衍生物的合成、结构及细胞毒性活性
Molecules. 2016 Jan 27;21(2):156. doi: 10.3390/molecules21020156.
8
Synthesis of 8-hydroxyquinoline derivatives as novel antitumor agents.新型抗肿瘤药物8-羟基喹啉衍生物的合成
ACS Med Chem Lett. 2012 Dec 20;4(2):170-4. doi: 10.1021/ml300238z. eCollection 2013 Feb 14.
9
Synthesis of new quinolinequinone derivatives and preliminary exploration of their cytotoxic properties.合成新型喹啉醌衍生物及其细胞毒性的初步探索。
J Med Chem. 2013 May 23;56(10):3806-19. doi: 10.1021/jm301689x. Epub 2013 May 1.
10
Synthesis and characterization of novel unsymmetrical and symmetrical 3-halo- or 3-methoxy-substituted 2-dibenzoylamino-1,4-naphthoquinone derivatives.新型不对称和对称 3-卤代或 3-甲氧基取代的 2-二苯甲酰氨基-1,4-萘醌衍生物的合成与表征。
Molecules. 2013 Feb 4;18(2):1973-84. doi: 10.3390/molecules18021973.
本文引用的文献
1
Lavendamycin antitumor agents: structure-based design, synthesis, and NAD(P)H:quinone oxidoreductase 1 (NQO1) model validation with molecular docking and biological studies.薰衣草霉素抗肿瘤剂：基于结构的设计、合成以及通过分子对接和生物学研究对NAD(P)H：醌氧化还原酶1（NQO1）模型进行验证
J Med Chem. 2008 Jun 12;51(11):3104-15. doi: 10.1021/jm701066a. Epub 2008 May 6.
2
Synthesis and evaluation of antitumor activity of novel N-acyllavendamycin analogues and quinoline-5,8-diones.新型N-酰基薰衣草霉素类似物和喹啉-5,8-二酮的合成及其抗肿瘤活性评价
Bioorg Med Chem. 2007 Jan 1;15(1):495-510. doi: 10.1016/j.bmc.2006.09.039. Epub 2006 Oct 10.
3
Novel lavendamycin analogues as antitumor agents: synthesis, in vitro cytotoxicity, structure-metabolism, and computational molecular modeling studies with NAD(P)H:quinone oxidoreductase 1.新型薰衣草霉素类似物作为抗肿瘤药物：合成、体外细胞毒性、结构代谢以及与NAD(P)H：醌氧化还原酶1的计算分子模拟研究
J Med Chem. 2005 Dec 1;48(24):7733-49. doi: 10.1021/jm050758z.
4
DT-diaphorase: a target for new anticancer drugs.DT-黄递酶：新型抗癌药物的一个靶点。
Cancer Treat Rev. 2004 Aug;30(5):437-49. doi: 10.1016/j.ctrv.2004.01.002.
5
Role of nicotinamide quinone oxidoreductase 1 (NQO1) in protection against toxicity of electrophiles and reactive oxygen intermediates.烟酰胺醌氧化还原酶1（NQO1）在抵御亲电试剂和活性氧中间体毒性中的作用。
Methods Enzymol. 2004;382:355-64. doi: 10.1016/S0076-6879(04)82019-6.
6
Novel quinolinequinone antitumor agents: structure-metabolism studies with NAD(P)H:quinone oxidoreductase (NQO1).新型喹啉醌类抗肿瘤药物：与NAD(P)H：醌氧化还原酶（NQO1）的结构-代谢研究
Bioorg Med Chem. 2004 Apr 1;12(7):1667-87. doi: 10.1016/j.bmc.2004.01.021.
7
Novel lavendamycin analogues as potent HIV-reverse transcriptase inhibitors: synthesis and evaluation of anti-reverse transcriptase activity of amide and ester analogues of lavendamycin.新型薰衣草霉素类似物作为有效的HIV逆转录酶抑制剂：薰衣草霉素酰胺和酯类似物的合成及抗逆转录酶活性评估
J Med Chem. 2003 Dec 18;46(26):5773-80. doi: 10.1021/jm0304414.
8
Preliminary observations on the use of streptonigrin as an antitumor agent in human beings.关于链黑菌素作为一种抗肿瘤药物在人体中应用的初步观察。
Antibiot Chemother (Northfield). 1961 Mar;11:147-50.
9
Clinical observations on the effects of streptonigrin in patients with neoplastic disease.链黑菌素对肿瘤疾病患者疗效的临床观察
Antibiot Chemother (Northfield). 1961 Mar;11:178-83.
10
Characterization of the cytotoxic activities of novel analogues of the antitumor agent, lavendamycin.抗肿瘤药物薰衣草霉素新型类似物的细胞毒性活性表征
Mol Cancer Ther. 2003 Jun;2(6):517-26.
Zotero 插件